Publicação

Target identification of situations of improvement through Medication Review in patients type 2 diabetes

Ver documento

Detalhes bibliográficos
Resumo:Introduction: Prevention, early detection and management of diabetes are fundamental for stopping this present epidemic. Medication review may contribute to the early detection of negative clinical outcomes risk factors associated to the use of medicines. Aims: To use the medication review to identify the situations that may lead to clinical negative outcomes, described as findings, in the process of medicines use in type 2 diabetic patients. To verify if the inclusion criteria list of the Pharmaceutical Society of Australia for medication review allows identifying patients of higher risks of obtaining clinical negative outcomes.
Autores principais:Simoes, Ana Luisa
Outros Autores:Castel-Branco, Margarida; Caramona, M. Margarida; Fernandez-Llimos, Fernando; Figueiredo, Isabel V.
Ano:2013
País:Portugal
Tipo de documento:documento de conferência
Tipo de acesso:acesso restrito
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
_version_ 1866809810509365248
author Simoes, Ana Luisa
author2 Castel-Branco, Margarida
Caramona, M. Margarida
Fernandez-Llimos, Fernando
Figueiredo, Isabel V.
author2_role author
author
author
author
author_facet Simoes, Ana Luisa
Castel-Branco, Margarida
Caramona, M. Margarida
Fernandez-Llimos, Fernando
Figueiredo, Isabel V.
author_role author
contributor_name_str_mv Repositório Científico de Acesso Aberto da ULisboa
country_str PT
creators_json_txt [{\"Person.name\":\"Simoes, Ana Luisa\"},{\"Person.name\":\"Castel-Branco, Margarida\"},{\"Person.name\":\"Caramona, M. Margarida\"},{\"Person.name\":\"Fernandez-Llimos, Fernando\",\"Person.identifier.orcid\":\"0000-0002-8529-9595\"},{\"Person.name\":\"Figueiredo, Isabel V.\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
datacite.creators.creator.creatorName.fl_str_mv Simoes, Ana Luisa
Castel-Branco, Margarida
Caramona, M. Margarida
Fernandez-Llimos, Fernando
Figueiredo, Isabel V.
datacite.date.Accepted.fl_str_mv 2013-01-01T00:00:00Z
datacite.date.available.fl_str_mv 2015-04-15T17:53:01Z
datacite.date.embargoed.fl_str_mv 2015-04-15T17:53:01Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_16ec
datacite.titles.title.fl_str_mv Target identification of situations of improvement through Medication Review in patients type 2 diabetes
dc.contributor.none.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
dc.creator.none.fl_str_mv Simoes, Ana Luisa
Castel-Branco, Margarida
Caramona, M. Margarida
Fernandez-Llimos, Fernando
Figueiredo, Isabel V.
dc.date.Accepted.fl_str_mv 2013-01-01T00:00:00Z
dc.date.available.fl_str_mv 2015-04-15T17:53:01Z
dc.date.embargoed.fl_str_mv 2015-04-15T17:53:01Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10451/17935
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv FIP
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.title.fl_str_mv Target identification of situations of improvement through Medication Review in patients type 2 diabetes
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_c94f
description Introduction: Prevention, early detection and management of diabetes are fundamental for stopping this present epidemic. Medication review may contribute to the early detection of negative clinical outcomes risk factors associated to the use of medicines. Aims: To use the medication review to identify the situations that may lead to clinical negative outcomes, described as findings, in the process of medicines use in type 2 diabetic patients. To verify if the inclusion criteria list of the Pharmaceutical Society of Australia for medication review allows identifying patients of higher risks of obtaining clinical negative outcomes.
dirty 0
eu_rights_str_mv restrictedAccess
format conferenceObject
fulltext.url.fl_str_mv https://repositorio.ulisboa.pt/bitstreams/e3386192-1487-44db-9872-7f6c86c0b0ca/download
id ul_0fbd6ffa4ccea07be64d5ec1abdcfc01
identifier.url.fl_str_mv http://hdl.handle.net/10451/17935
instacron_str ul
institution Universidade de Lisboa
instname_str Universidade de Lisboa
language eng
network_acronym_str ul
network_name_str Repositório da Universidade de Lisboa
oai_identifier_str oai:repositorio.ulisboa.pt:10451/17935
organization_str_mv urn:organizationAcronym:ul
person_str_mv Simoes, Ana Luisa
Castel-Branco, Margarida
Caramona, M. Margarida
Fernandez-Llimos, Fernando
Fernandez-Llimos, Fernando
https://www.ciencia-id.pt/F716-B3AD-341A
F716-B3AD-341A
http://orcid.org/0000-0002-8529-9595
0000-0002-8529-9595
Figueiredo, Isabel V.
publishDate 2013
publisher.none.fl_str_mv FIP
reponame_str Repositório da Universidade de Lisboa
repository_id_str urn:repositoryAcronym:ul
service_str_mv urn:repositoryAcronym:ul
spelling engFIPporIntroduction: Prevention, early detection and management of diabetes are fundamental for stopping this present epidemic. Medication review may contribute to the early detection of negative clinical outcomes risk factors associated to the use of medicines. Aims: To use the medication review to identify the situations that may lead to clinical negative outcomes, described as findings, in the process of medicines use in type 2 diabetic patients. To verify if the inclusion criteria list of the Pharmaceutical Society of Australia for medication review allows identifying patients of higher risks of obtaining clinical negative outcomes.application/pdfporTarget identification of situations of improvement through Medication Review in patients type 2 diabetesSimoes, Ana LuisaCastel-Branco, MargaridaCaramona, M. MargaridaPersonalFernandez-Llimos, FernandoDSpacehttp://dspace.org/items/7787f062-8cd7-4a52-80a2-db5f49fd05acDSpacehttp://dspace.org/items/7787f062-8cd7-4a52-80a2-db5f49fd05acFernandez-LlimosFernandoCiência IDhttps://www.ciencia-id.ptF716-B3AD-341AORCIDhttp://orcid.org0000-0002-8529-9595Scopus Author IDhttps://www.scopus.com56366491700Figueiredo, Isabel V.HostingInstitutionOrganizationalRepositório Científico de Acesso Aberto da ULisboae-mailmailto:repositorio@reitoria.ulisboa.ptrepositorio@reitoria.ulisboa.pt2015-04-15T17:53:01Z20132014-12-13T12:25:12Z2013-01-01T00:00:00ZHandlehttp://hdl.handle.net/10451/17935http://purl.org/coar/access_right/c_16ecrestricted access286872 bytesother research producthttp://purl.org/coar/resource_type/c_c94fconference objecthttp://purl.org/coar/access_right/c_16ecapplication/pdffulltexthttps://repositorio.ulisboa.pt/bitstreams/e3386192-1487-44db-9872-7f6c86c0b0ca/downloadFIP World Congress 20132013Dublin
spellingShingle Target identification of situations of improvement through Medication Review in patients type 2 diabetes
Simoes, Ana Luisa
status SINGLETON
title Target identification of situations of improvement through Medication Review in patients type 2 diabetes
title_full Target identification of situations of improvement through Medication Review in patients type 2 diabetes
title_fullStr Target identification of situations of improvement through Medication Review in patients type 2 diabetes
title_full_unstemmed Target identification of situations of improvement through Medication Review in patients type 2 diabetes
title_short Target identification of situations of improvement through Medication Review in patients type 2 diabetes
title_sort Target identification of situations of improvement through Medication Review in patients type 2 diabetes
url http://hdl.handle.net/10451/17935
visible 1